CLINICAL RESEARCH: VALVULAR HEART DISEASE
Neoangiogenesis, T-lymphocyte infiltration, and heat shock protein-60 are biological hallmarks of an immunomediated inflammatory process in end-stage calcified aortic valve stenosis
Annamaria Mazzone, MD*,*,
Maria Carmela Epistolato, BSc ,
Raffaele De Caterina, MD, PhD,
Simona Storti, BSc ,
Simona Vittorini, PhD*,
Silverio Sbrana, MD, PhD*,
Jacopo Gianetti, MD, PhD*,
Stefano Bevilacqua, MD*,
Mattia Glauber, MD*,
Andrea Biagini, MD* and
Piero Tanganelli, MD
* CNR Institute of Clinical Physiology, Ospedale Pasquinucci, Massa, Italy
Department of Pathology, University of Siena, Siena, Italy
Chair of Cardiology, "G. d'Annunzio" University, Chieti, Italy
Manuscript received May 30, 2003;
revised manuscript received November 26, 2003,
accepted December 1, 2003.
* Reprint requests and correspondence: Dr. Annamaria Mazzone, Department of Cardiology and Cardiac Surgery, Ospedale G. Pasquinucci, 54100 Massa, Italy.
mazzone{at}ifc.cnr.it
OBJECTIVES: We investigated the main biomolecular features in the evolution of aortic stenosis, focusing on advanced lesions.
BACKGROUND: "Degenerative" aortic valve stenosis shares risk factors and inflammatory similarities with atherosclerosis.
METHODS: We compared nonrheumatic stenotic aortic valves from 26 patients undergoing surgical valve replacement (group A) and 14 surgical control patients (group B). We performed semiquantitative histological and immunohistochemical analyses on valve leaflets to measure inflammation, sclerosis, calcium, neoangiogenesis, and intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) expression. We assessed heat shock protein 60 (hsp60) gene expression as an index of cellular stress and C-reactive protein, erythrocyte sedimentation rate, and fibrinogen as systemic inflammatory markers.
RESULTS: In group A valves, we found a prevalence of calcium nodules surrounded by activated inflammatory infiltrates, neovessels, and abundant ICAM-1, VCAM-1, and hsp60 gene expression. Specimens from group B were negative for all of these markers, except 2 of 14 positivity for hsp60. The presence of active inflammatory infiltrates correlated with an abundance of thin neovessels (p < 0.01) and hsp60 gene expression (p = 0.01), whereas neoangiogenesis correlated with inflammation (p = 0.04), calcium (p = 0.01), and hsp60 gene expression (p = 0.04).
CONCLUSIONS: "Degenerative" aortic valve stenosis appears to be a chronic inflammatory process associated with atherosclerotic risk factors. The coexistence of neoangiogenesis, T-lymphocyte infiltration, adhesion molecules, and hsp60 gene expression indicates an active immunomediated process in the final phases of the disease.
|
Abbreviations and Acronyms
| | CRP | = C-reactive protein | | DNA | = deoxyribonucleic acid | | ESR | = erythrocyte sedimentation rate | | GAPDH | = glyceraldehyde-3-phosphate dehydrogenase | | HE | = hematoxylin-eosin | | hsp60 | = heat shock protein-60 | | ICAM-1 | = intercellular adhesion molecule-1 | | LDL | = low-density lipoprotein | | mRNA | = messenger ribonucleic acid | | PBS | = phosphate-buffered saline | | PCR | = polymerase chain reaction | | RT | = reverse transcription | | VCAM-1 | = vascular cell adhesion molecule-1 | | WVG | = Weigert-van Gieson |
|
This article has been cited by other articles:
|
|
|
|
 
K Akat, M Borggrefe, and J J Kaden
Aortic valve calcification: basic science to clinical practice
Heart,
April 1, 2009;
95(8):
616 - 623.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Parolari, C. Loardi, L. Mussoni, L. Cavallotti, M. Camera, P. Biglioli, E. Tremoli, and F. Alamanni
Nonrheumatic calcific aortic stenosis: an overview from basic science to pharmacological prevention
Eur. J. Cardiothorac. Surg.,
March 1, 2009;
35(3):
493 - 504.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Matsumoto, V. Adams, C. Walther, C. Kleinecke, P. Brugger, A. Linke, T. Walther, F. W. Mohr, and G. Schuler
Reduced number and function of endothelial progenitor cells in patients with aortic valve stenosis: a novel concept for valvular endothelial cell repair
Eur. Heart J.,
February 1, 2009;
30(3):
346 - 355.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Toutouzas, M. Drakopoulou, A. Synetos, E. Tsiamis, G. Agrogiannis, N. Kavantzas, E. Patsouris, D. Iliopoulos, S. Theodoropoulos, M. Yacoub, et al.
In Vivo Aortic Valve Thermal Heterogeneity in Patients With Nonrheumatic Aortic Valve Stenosis: The First In Vivo Experience in Humans
J. Am. Coll. Cardiol.,
August 26, 2008;
52(9):
758 - 763.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. D. Wu, M. S. Maurer, R. A. Friedman, C. C. Marboe, E. M. Ruiz-Vazquez, R. Ramakrishnan, A. Schwartz, M. D. Tilson, A. S. Stewart, and R. Winchester
The Lymphocytic Infiltration in Calcific Aortic Stenosis Predominantly Consists of Clonally Expanded T Cells
J. Immunol.,
April 15, 2007;
178(8):
5329 - 5339.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A Charest, A Pepin, R Shetty, C Cote, P Voisine, F Dagenais, P Pibarot, and P Mathieu
Distribution of SPARC during neovascularisation of degenerative aortic stenosis
Heart,
December 1, 2006;
92(12):
1844 - 1849.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Helske, S. Syvaranta, K. A. Lindstedt, J. Lappalainen, K. Oorni, M. I. Mayranpaa, J. Lommi, H. Turto, K. Werkkala, M. Kupari, et al.
Increased Expression of Elastolytic Cathepsins S, K, and V and Their Inhibitor Cystatin C in Stenotic Aortic Valves
Arterioscler. Thromb. Vasc. Biol.,
August 1, 2006;
26(8):
1791 - 1798.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. Liebe, M. Brueckmann, M. Borggrefe, and J. J. Kaden
Statin therapy of calcific aortic stenosis: hype or hope?
Eur. Heart J.,
April 1, 2006;
27(7):
773 - 778.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D Skowasch, S Schrempf, C J Preusse, J A Likungu, A Welz, B Luderitz, and G Bauriedel
Tissue resident C reactive protein in degenerative aortic valves: correlation with serum C reactive protein concentrations and modification by statins
Heart,
April 1, 2006;
92(4):
495 - 498.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Skowasch, S. Schrempf, N. Wernert, M. Steinmetz, A. Jabs, I. Tuleta, U. Welsch, C. J. Preusse, J. A. Likungu, A. Welz, et al.
Cells of primarily extravalvular origin in degenerative aortic valves and bioprostheses
Eur. Heart J.,
December 1, 2005;
26(23):
2576 - 2580.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. H. Rahimtoola
The year in valvular heart disease
J. Am. Coll. Cardiol.,
January 4, 2005;
45(1):
111 - 122.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. N. DeMaria, O. Ben-Yehuda, D. Berman, G. K. Feld, B. H. Greenberg, J. D. Knoke, K. U. Knowlton, W. Y.W. Lew, J. Narula, D. Sahn, et al.
Highlights of the year in JACC 2004
J. Am. Coll. Cardiol.,
January 4, 2005;
45(1):
137 - 153.
[Full Text]
[PDF]
|
|
|
|
